Back to top

earnings-report: Archive

Zacks Equity Research

Rigetti Computing (RGTI) Down 10.1% Since Last Earnings Report: Can It Rebound?

Rigetti Computing (RGTI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?

CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Editas (EDIT) Down 8.3% Since Last Earnings Report: Can It Rebound?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Green Dot (GDOT) Up 15.2% Since Last Earnings Report: Can It Continue?

Green Dot (GDOT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

AST SpaceMobile (ASTS) Up 7.3% Since Last Earnings Report: Can It Continue?

AST SpaceMobile (ASTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Barrick Mining (B) Up 14.2% Since Last Earnings Report?

Barrick Mining (B) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

American Public Education (APEI) Up 1% Since Last Earnings Report: Can It Continue?

American Public Education (APEI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Anirudha Bhagat

How Should Investors Play Salesforce Stock After Q3 Earnings Beat?

CRM pops on Q3 earnings beat as AI offerings surge, but slowing sales growth tempers the momentum for investors weighing their next move.

Urmimala Biswas

Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run?

Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.

Urmimala Biswas

Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook

Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.